Christopher Marlett is the Chief Executive Officer, Chairman of the Board, and a Director of MDB Capital Holdings. He co-founded MDB Capital in 1997. Over a career spanning nearly four decades, he has become a driving force in the financing and public launch of innovative, venture-stage companies—having led 18 IPOs for high-growth technology and life sciences firms. Christopher has dedicated his career to pioneering a distinctive method for bringing breakthrough businesses to the public markets, with a focus on establishing companies as leaders in emerging technology categories and providing investors with superior access to promising opportunities versus traditional venture capital routes.
Under his stewardship, MDB Capital has purposefully optimized the path from innovation to market leadership through strategies that integrate the development of dominant intellectual property positions. This process led to the founding of PatentVest, an MDB-owned IP legal services firm and business intelligence platform, which has become a cornerstone in shepherding novel technology platforms to commercial success. He has also co-founded or shaped the commercialization and financing strategies for every company MDB has taken public, frequently serving as an active board member during their formative stages.
Christopher’s experience extends deeply into the biotechnology sector, where he has helped launch several life science companies that achieved FDA approval for products addressing large market needs, resulting in multi-billion-dollar valuations or successful acquisitions by major pharmaceutical companies. He is also recognized for fostering international economic development, notably in Nicaragua, where he led impactful investments and ventures that created thousands of local jobs, developed Central America’s largest call center park, and built pioneering knowledge process outsourcing and intellectual property services operations.
A graduate of the University of Southern California with a BS in Business Administration, Christopher is known as an advocate for disruptive innovation and as a thought leader in public venture capital. His vision, expertise, and leadership have positioned MDB Capital as a unique gateway for investors and inventors seeking to build and scale the next generation of transformative technology companies.
What is Christopher A. Marlett's net worth?
The estimated net worth of Christopher A. Marlett is at least $418.04 thousand as of January 2nd, 2026. Mr. Marlett owns 169,933 shares of MDB Capital stock worth more than $418,035 as of September 30th. This net worth estimate does not reflect any other investments that Mr. Marlett may own. Learn More about Christopher A. Marlett's net worth.
How do I contact Christopher A. Marlett?
Has Christopher A. Marlett been buying or selling shares of MDB Capital?
Christopher A. Marlett has not been actively trading shares of MDB Capital during the last ninety days. Most recently, on Friday, January 2nd, Christopher A. Marlett bought 1,213 shares of MDB Capital stock. The stock was acquired at an average cost of $3.50 per share, with a total value of $4,245.50. Following the completion of the transaction, the insider now directly owns 169,933 shares of the company's stock, valued at $594,765.50. Learn More on Christopher A. Marlett's trading history.
Who are MDB Capital's active insiders?
Are insiders buying or selling shares of MDB Capital?
In the last year, MDB Capital insiders bought shares 12 times. They purchased a total of 29,248 shares worth more than $99,567.47. In the last year, insiders at the sold shares 1 times. They sold a total of 60 shares worth more than $200.40. The most recent insider tranaction occured on January, 23rd when CFO Jeremy William James sold 60 shares worth more than $200.40. Insiders at MDB Capital own 55.8% of the company.
Learn More about insider trades at MDB Capital. Information on this page was last updated on 1/23/2026.
